136 related articles for article (PubMed ID: 8300411)
1. A new microcellular cytotoxicity test based on calcein AM release.
Wang XM; Terasaki PI; Rankin GW; Chia D; Zhong HP; Hardy S
Hum Immunol; 1993 Aug; 37(4):264-70. PubMed ID: 8300411
[TBL] [Abstract][Full Text] [Related]
2. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology.
Roden MM; Lee KH; Panelli MC; Marincola FM
J Immunol Methods; 1999 Jun; 226(1-2):29-41. PubMed ID: 10410969
[TBL] [Abstract][Full Text] [Related]
3. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.
Papadopoulos NG; Dedoussis GV; Spanakos G; Gritzapis AD; Baxevanis CN; Papamichail M
J Immunol Methods; 1994 Dec; 177(1-2):101-11. PubMed ID: 7822816
[TBL] [Abstract][Full Text] [Related]
4. Calcein AM release-based cytotoxic cell assay for fish leucocytes.
Iwanowicz LR; Densmore CL; Ottinger CA
Fish Shellfish Immunol; 2004 Feb; 16(2):127-37. PubMed ID: 15123317
[TBL] [Abstract][Full Text] [Related]
5. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
6. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity.
Lichtenfels R; Biddison WE; Schulz H; Vogt AB; Martin R
J Immunol Methods; 1994 Jun; 172(2):227-39. PubMed ID: 7518485
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of natural killer cytotoxicity in vitro by clinical grade serine protease inhibitors.
Yamamoto M; Saigo K; Koshiba M; Kitamura N; Horie O; Ryo R; Kumagai S
Haematologia (Budap); 2002; 32(2):103-11. PubMed ID: 12412729
[TBL] [Abstract][Full Text] [Related]
8. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
[TBL] [Abstract][Full Text] [Related]
9. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.
Neri S; Mariani E; Meneghetti A; Cattini L; Facchini A
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1131-5. PubMed ID: 11687452
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
Wierda WG; Mehr DS; Kim YB
J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
[TBL] [Abstract][Full Text] [Related]
11. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
[TBL] [Abstract][Full Text] [Related]
12. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
Hermann GG; Zeuthen J; Claësson MH
Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
[TBL] [Abstract][Full Text] [Related]
13. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
14. Single-colour flow cytometric assay to determine NK cell-mediated cytotoxicity and viability against non-adherent human tumor cells.
Thakur A; Zaman A; Hummel J; Jones K; Hortelano G
Biotechnol Lett; 2012 Mar; 34(3):447-53. PubMed ID: 22187077
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF).
Kolber MA; Quinones RR; Gress RE; Henkart PA
J Immunol Methods; 1988 Apr; 108(1-2):255-64. PubMed ID: 3258339
[TBL] [Abstract][Full Text] [Related]
16. Cell mediated cytotoxicity assessment by relative changes in viable target absolute counts.
Topakas GN; Karchilaki IN; Cacoullos NT; Stavropoulos-Giokas C
Immunopharmacol Immunotoxicol; 2001 Aug; 23(3):459-75. PubMed ID: 11694035
[TBL] [Abstract][Full Text] [Related]
17. Quantification of effector/target conjugation involving natural killer (NK) or lymphokine activated killer (LAK) cells by two-color flow cytometry.
Radcliff G; Waite R; LeFevre J; Poulik MD; Callewaert DM
J Immunol Methods; 1991 Jun; 139(2):281-92. PubMed ID: 2045664
[TBL] [Abstract][Full Text] [Related]
18. Screening of high cytotoxic tumor killer cells using a sensitive adherent target detachment assay.
Wang X; Cai J; Zhong H; Denham SA; Terasaki PI
J Immunol Methods; 2004 Dec; 295(1-2):57-65. PubMed ID: 15627611
[TBL] [Abstract][Full Text] [Related]
19. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
Dannemann BR; Morris VA; Araujo FG; Remington JS
J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay.
Lorenzo-Herrero S; Sordo-Bahamonde C; González S; López-Soto A
Methods Enzymol; 2020; 631():483-495. PubMed ID: 31948565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
